Clinical Research Directory
Browse clinical research sites, groups, and studies.
Feasibility of Individualized, Model-guided Optimization of Proton Beam Treatment Planning in Patients With Low Grade Glioma
Sponsor: University Hospital Heidelberg
Summary
Low-grade glioma (LGG) represent typically slowly growing primary brain tumors with world health organization (WHO) grade I or II who affect young adults around their fourth decade. Radiological feature on MRI is a predominantly T2 hyperintense signal, LGG show typically no contrast uptake. Radiotherapy plays an important role in the treatment of LGG. However, not least because of the good prognosis with long term survivorship the timing of radiotherapy has been discussed controversially. In order to avoid long term sequelae such as neurocognitive impairment, malignant transformation or secondary neoplasms initiation was often postponed as long as possible
Official title: Prospective Phase II Trial to Assess Feasibility of Individualized, Model-guided Optimization of Proton Beam Treatment Planning in Patients With Low Grade Glioma Multicentric, Prospective Interventional, Randomized, Observer Blind Two Arm (Active Control), Parallel Group Investigator-initiated Phase II Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2023-11-11
Completion Date
2028-11-11
Last Updated
2024-01-05
Healthy Volunteers
No
Conditions
Interventions
model-guided optimization of treatment plan
original treatmant plans are optimized based on model-based NTCP
standard treatment plan, no optimization
original treatment plans are not optimized
Locations (1)
Department of Radiotherapy, University of Heidelberg
Heidelberg, Germany